Anebulo Pharmaceuticals ANEB
OTC ANEB
$0.32 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Anebulo Pharmaceuticals (ANEB) Selling, General & Administrative (2020 - 2025)

Updated

Anebulo Pharmaceuticals (ANEB) reported Selling, General & Administrative of $1.46 million for fiscal Q2 2026 (quarter ended Dec 31, 2025), up 6.4% from $1.37 million a year earlier and up 0.3% from the prior quarter.

Analysis

Anebulo Pharmaceuticals (ANEB) Selling, General & Administrative (2020 - 2025) Analysis & Trends

Over the twelve months ended Dec 31, 2025, Anebulo Pharmaceuticals' Selling, General & Administrative came in at $5.36 million, up 26.1% year-over-year; for FY2025 (ended Jun 30, 2025), it was $4.92 million, up 3.4% from FY2024.

  • Selling, General & Administrative has a five-year compound annual growth rate of 191.6% (FY2020 to FY2025).
  • By fiscal year, Selling, General & Administrative came in at $4.76 million in FY2024 (-23.0%), $6.18 million in FY2023 (+59.8%), $3.87 million in FY2022 (+188.0%) and $1.34 million in FY2021.
  • The fiscal Q2 2026 figure ranks as the highest quarterly Selling, General & Administrative since fiscal Q2 2024.
  • Year over year, Selling, General & Administrative has now increased in each of the last four quarters, with growth averaging 1.6% over the last eight quarters.
  • The high point for year-over-year Selling, General & Administrative in five years was fiscal Q2 2022 (growth of 455.1%); the low point was fiscal Q3 2024 (a decline of 48.4%).
  • Per Business Quant data, the three fiscal quarters before Q2 2026 came in at $1.45 million (Q1 2026), $1.2 million (Q4 2025) and $1.25 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Anebulo Pharmaceuticals 13.15 Mn 13.15 Mn - 1.46 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.46 Mn
Sep 30, 2025 1.45 Mn
Jun 30, 2025 1.20 Mn
Mar 31, 2025 1.25 Mn
Dec 31, 2024 1.37 Mn
Sep 30, 2024 1.10 Mn
Jun 30, 2024 872,661.00
Mar 31, 2024 915,912.00
Dec 31, 2023 1.70 Mn
Sep 30, 2023 1.27 Mn
Jun 30, 2023 1.08 Mn
Mar 31, 2023 1.77 Mn
Dec 31, 2022 1.94 Mn
Sep 30, 2022 1.39 Mn
Jun 30, 2022 1.21 Mn
Mar 31, 2022 964,281.00
Dec 31, 2021 858,186.00
Sep 30, 2021 839,826.00
Jun 30, 2021 678,013.00
Mar 31, 2021 279,093.00
API Access

Anebulo Pharmaceuticals Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=ANEB&period=max&api_key=YOUR_API_KEY